News

Celiac Disease (CD)- Market Insights, Epidemiology and Market Forecast-2023




Description

“Celiac Disease (CD)- Market Insights, Epidemiology and Market Forecast-2023” report provides an overview of the disease and global market size of the Celiac Disease for the 6MM (United States and EU5 countries (France, Germany, Italy, Spain and UK)). It also includes global historical and forecasted epidemiological data for the diagnosed prevalent cases of Celiac Disease from 2013-2023.

Celiac disease is a genetic autoimmune disease where the indigestion of gluten leads to damage in the small intestine. The number of ways celiac disease can affect patients, combined with a lack of training in medical schools and primary care residency programs, contributes to the poor diagnosis rate. Currently it is estimated that 80% of the celiac disease population remains undiagnosed. Prevalence in Western Europe and in the United States ranges between 1 in 250 and 1 in 133. It is higher in relatives of people with celiac disease. Women are affected more commonly than men, but there is no age predilection. forecasts predict that the total prevalent cases of Celiac Disease is expected to accentuate up to 4.69 Million by 2023 at a Compound Annual Growth Rate (CAGR) of 0.46% from 2013-2023 while the diagnosed prevalent population of Celiac Disease in the 6MM shall grow at a CAGR of 0.15% for the forecast period (2013-2023).

Get a PDF Sample of Report at: http://www.orbisresearch.com/contacts/request-sample/209364   .

There is no targeted therapy approved for celiac disease. The current standard of care treatment involves a gluten free diet (GFD). Steroids and immunosuppressants are used to reduce symptoms in severe cases. Owing to the expected launch of Larazotide Acetate (Innovate Pharmaceuticals) in 2021 followed by the launch of Latiglutenase (ImmunogenX/Abbvie) in 2023, shall lead to a hike in the otherwise stable, worldwide market size of celiac disease. estimates suggest that the global market size is expected to grow at a CAGR of 19% from 2013-2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

– Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.

– It focuses on the detailed historical and forecasted number of total prevalent cases as well as diagnosed prevalent cases of Celiac Disease for 6MM from 2013-2023.

– The Report also includes historical and forecasted Market size of Celiac Disease for 6MM from 2013 to 2023.

– It provides the information of available marketed therapies, including off-label biologics, patent and exclusivity details.

– The report also focuses on the details of pipeline drugs in the pivotal stage of development including their SWOT Analysis and expected launch date, which shall help to predict the impact of those drugs on the market size in the near future.

To Browse the Entire Report, Visit : http://www.orbisresearch.com/reports/index/celiac-disease-cd-market-insights-epidemiology-and-market-forecast-2023 .

The Key Players Mentioned in Report are:

Report Introduction

Celiac Disease Market Size Overview at a Glance

·         Worldwide Market Size of Celiac Disease in 2013

·         Worldwide Market Size of Celiac Disease in 2023

Celiac Disease Overview

Celiac Disease Types

·         Non-Responsive or Refractory CD

·         Etiology

·         Symptoms

·         Diagnosis

·         Disease Management

·         Disease Treatment

·         Treatment of Celiac Disease

Treatment of Non-Responsive or Refractory Celiac Disease (RCD)

·         Current Unmet Medical Needs

·         Epidemiology Parameters

·         Iceberg Model

·         Genetic Predisposition

·         Epidemiology &Patient Population

United States

·         Diagnosed Prevalent Cases of Celiac Disease in United States (2013-2023)

EU5 Countries

France

·         Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)

Germany

·         Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)

Italy

·         Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)

Spain

·         Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)

United Kingdom

·         Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)

Place a Purchase Order for this Report at: http://www.orbisresearch.com/contact/purchase/209364  .

Got any Query? Feel free to ask us at : http://www.orbisresearch.com/contacts/enquiry-before-buying/209364






Most Popular

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem?

Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet.

Copyright © 2015 All-In World News.

To Top